BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3065338)

  • 1. Use of 5% sulfamylon (mafenide) solution after excision and grafting of burns.
    Lee JJ; Marvin JA; Heimbach DM; Grube BJ
    J Burn Care Rehabil; 1988; 9(6):602-5. PubMed ID: 3065338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The "Sulfamylon sandwich"--a laminated mafenide-saline dressing.
    Buehler PK; Reading GP; Jacoby FG; Harrison HN
    Ann Plast Surg; 1980 Aug; 5(2):157-9. PubMed ID: 7004316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mafenide acetate solution dressings: an adjunct in burn wound care.
    Shuck JM; Thorne LW; Cooper CG
    J Trauma; 1975 Jul; 15(7):595-9. PubMed ID: 1097720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A silver-coated antimicrobial barrier dressing used postoperatively on meshed autografts: a dressing comparison study.
    Silver GM; Robertson SW; Halerz MM; Conrad P; Supple KG; Gamelli RL
    J Burn Care Res; 2007; 28(5):715-9. PubMed ID: 17667837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antifibrinolytic activity of sulfamylon solution.
    Aldridge JH; Weisdorf DJ; Kucan JO
    Plast Reconstr Surg; 1988 Aug; 82(2):281-4. PubMed ID: 3041428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five percent mafenide acetate solution in the treatment of thermal injuries.
    Kucan JO; Smoot EC
    J Burn Care Rehabil; 1993; 14(2 Pt 1):158-63. PubMed ID: 8501103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Sulfamylon cream inhibits DNA and protein synthesis in the skin donor site wound.
    Zhang XJ; Heggers JP; Chinkes DL; Wolf SE; Hawkins HK; Wolfe RR
    Surgery; 2006 May; 139(5):633-9. PubMed ID: 16701096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of 5% Sulfamylon solution for the treatment of contaminated explanted human meshed skin grafts.
    Maggi SP; Soler PM; Smith PD; Hill DP; Ko F; Robson MC
    Burns; 1999 May; 25(3):237-41. PubMed ID: 10323608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical sulfamylon reduces engraftment of cultured skin substitutes on athymic mice.
    Boyce ST; Supp AP; Swope VB; Warden GD
    J Burn Care Rehabil; 1999; 20(1 Pt 1):33-6. PubMed ID: 9934634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of burns under conditions of limited resources using topical aqueous sulfamylon (mafenide) hydrochloride spray.
    Mendelson JA
    J Burn Care Rehabil; 1997; 18(3):238-44. PubMed ID: 9169948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the pain produced by mafenide acetate preparations in burns.
    Harrison HN; Shuck JM; Caldwell E
    Arch Surg; 1975 Dec; 110(12):1446. PubMed ID: 981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfamylon solution dressings in the management of burn wounds: preliminary clinical report.
    Shuck JM; Einfeldt LE; Trainor MP
    J Trauma; 1972 Nov; 12(11):999-1002. PubMed ID: 4629266
    [No Abstract]   [Full Text] [Related]  

  • 13. Seven years' experience with Integra as a reconstructive tool.
    Jeng JC; Fidler PE; Sokolich JC; Jaskille AD; Khan S; White PM; Street JH; Light TD; Jordan MH
    J Burn Care Res; 2007; 28(1):120-6. PubMed ID: 17211211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of topical mafenide acetate application on skin graft survival in bacterial contaminated wounds.
    Baver Acaban M; Sarı A; Demirbağ HO; Ersöz G; Aktaş S
    Burns; 2024 Mar; 50(2):433-443. PubMed ID: 37985270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic absorption of amphotericin B with topical 5% mafenide acetate/amphotericin B solution for grafted burn wounds: is it clinically relevant?
    Pendleton RA; Holmes JH
    Burns; 2010 Feb; 36(1):38-41. PubMed ID: 19481350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventilatory patterns following burn injury and effect of sulfamylon.
    Petroff PA; Hander EW; Mason AD
    J Trauma; 1975 Aug; 15(8):650-6. PubMed ID: 1152087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Pseudomonas burn wound infection by mafenide dry foam.
    Catania PN; King JC
    J Pharm Sci; 1975 Feb; 64(2):339-40. PubMed ID: 805232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical mafenide hydrochloride aqueous spray in initial management of massive contaminated wounds with devitalized tissue.
    Mendelson JA
    Prehosp Disaster Med; 2001; 16(3):172-4. PubMed ID: 11875802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2.5% Mafenide Acetate: A Cost-Effective Alternative to the 5% Solution for Burn Wounds.
    Afshari A; Nguyen L; Kahn SA; Summitt B
    J Burn Care Res; 2017; 38(1):e42-e47. PubMed ID: 27606553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfamylon allergy simulating chondritis.
    Kroll SS; Gerow FJ
    Plast Reconstr Surg; 1987 Aug; 80(2):298-9. PubMed ID: 3602182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.